These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21647134)

  • 1. Heat shock and awe.
    Dolgin E; Motluk A
    Nat Med; 2011 Jun; 17(6):646-9. PubMed ID: 21647134
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and application of Hsp90 inhibitors.
    Solit DB; Chiosis G
    Drug Discov Today; 2008 Jan; 13(1-2):38-43. PubMed ID: 18190862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparasitic and Antifungal Medications for Targeting Cancer Cells Literature Review and Case Studies.
    Guilford FT; Yu S
    Altern Ther Health Med; 2019 Jul; 25(4):26-31. PubMed ID: 31202208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics update.
    Southern PM
    Compr Ther; 1997 Sep; 23(9):575-82. PubMed ID: 9285157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiviral, antiparasitic and antifungal prescription in adults and children].
    Patrat-Delon S; Revest M; Tattevin P
    Rev Prat; 2014 Sep; 64(7):1015-25. PubMed ID: 25362796
    [No Abstract]   [Full Text] [Related]  

  • 6. [Infectiology and tropical medicine 2007].
    Löbermann M; Reisinger EC
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1399-403. PubMed ID: 17570089
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibiting the molecular evolution of cancer through HSP90.
    Martins AS; Davies FE; Workman P
    Oncotarget; 2012 Oct; 3(10):1054-6. PubMed ID: 23175477
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternate strategies of Hsp90 modulation for the treatment of cancer and other diseases.
    Brandt GE; Blagg BS
    Curr Top Med Chem; 2009; 9(15):1447-61. PubMed ID: 19860731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90 Inhibitors in Parasitic Nematodes: Prospects and Challenges.
    Devaney E; Gillan V
    Curr Top Med Chem; 2016; 16(25):2805-11. PubMed ID: 27072703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-shock protein 90: potential involvement in the pathogenesis of malignancy and pharmacological intervention.
    Ochel HJ; Gademann G
    Onkologie; 2002 Oct; 25(5):466-73. PubMed ID: 12415202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting HSP90 for cancer therapy.
    Mahalingam D; Swords R; Carew JS; Nawrocki ST; Bhalla K; Giles FJ
    Br J Cancer; 2009 May; 100(10):1523-9. PubMed ID: 19401686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?
    Dalhoff A
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):661-8. PubMed ID: 25515946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly adenosine diphosphate-ribose polymerase inhibitors and heat shock protein 90 inhibitors.
    Riely GJ
    J Thorac Oncol; 2011 Nov; 6(11 Suppl 4):S1803-4. PubMed ID: 22005537
    [No Abstract]   [Full Text] [Related]  

  • 14. New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy.
    Bogush TA; Polezhaev BB; Dudko EA; Bogush EA; Kirsanov VY; Polotsky BE; Tjuljandin SA; Davydov MI
    Antibiot Khimioter; 2016 Aug; 61():41-49. PubMed ID: 29874452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein 90: a unique chemotherapeutic target.
    Cullinan SB; Whitesell L
    Semin Oncol; 2006 Aug; 33(4):457-65. PubMed ID: 16890800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat Shock Protein 90 Inhibition in Cancer Drug Discovery: From Chemistry to Futural Clinical Applications.
    Özgür A; Tutar Y
    Anticancer Agents Med Chem; 2016; 16(3):280-90. PubMed ID: 26295332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells.
    Xu W; Neckers L
    Clin Cancer Res; 2007 Mar; 13(6):1625-9. PubMed ID: 17363512
    [No Abstract]   [Full Text] [Related]  

  • 18. U.S. Public Health Service/Infectious Diseases Society of America (USPHS/IDSA) guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary.
    Pediatr AIDS HIV Infect; 1995 Dec; 6(6):372-96. PubMed ID: 11361464
    [No Abstract]   [Full Text] [Related]  

  • 19. Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
    Lamoth F; Juvvadi PR; Steinbach WJ
    Crit Rev Microbiol; 2016; 42(2):310-21. PubMed ID: 25243616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
    Chiosis G; Caldas Lopes E; Solit D
    Curr Opin Investig Drugs; 2006 Jun; 7(6):534-41. PubMed ID: 16784024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.